30
300255•SHE•Healthcare•China•$40.14B
Stocks Similar to 300255
Top 20 stocks similar to Hebei Changshan Biochem Pharma based on sector, industry, market cap, and valuation multiples. Same-industry peers (Biotechnology) are ranked first.
| Company | Market Cap | Change | Compare |
|---|---|---|---|
 Alnylam Pharmaceuticals Inc ALNY • United States | $41.32B | -3.65% | vs |
 BeOne Medicines AG 6160 • Hong Kong | $36.45B | -3.56% | vs |
 argenx SE ARGNF • United States | $46.65B | +0.00% | vs |
 BeiGene Ltd. BEIGF • United States | $34.25B | +0.00% | vs |
CM CSL Limited CMXHF • United States | $47.28B | -1.49% | vs |
CS CSL Ltd CSLLY • United States | $48.12B | -2.23% | vs |
 CSL Ltd CSL • Australia | $48.60B | -0.40% | vs |
 Samsung Biologics Co Ltd 207940 • South Korea | $50.58B | +0.00% | vs |
68 BeiGene Ltd. 688235 • China | $52.07B | -6.57% | vs |
 Celltrion Inc 068270 • South Korea | $30.69B | -2.87% | vs |
 Argen-X ARGX • Belgium | $52.66B | -3.41% | vs |
AR argenx NV ADR ARGX • United States | $53.06B | -2.77% | vs |
 UCB SA UCB • Belgium | $59.26B | -4.48% | vs |
22 BioNTech SE 22UA • Germany | $26.75B | +9.61% | vs |
BN BioNTech SE BNTX • United States | $22.88B | +9.28% | vs |
0Q Moderna, Inc. 0QF • Germany | $22.78B | +1.89% | vs |
SB Sino Biopharmaceutical Ltd ADR SBHMY • United States | $22.32B | +0.00% | vs |
 WuXi Biologics 2269 • Hong Kong | $19.82B | -5.06% | vs |
18 Innovent Biologics Inc 1801 • Hong Kong | $19.71B | -2.76% | vs |
IV IVBIY IVBIY • United States | $18.19B | +0.00% | vs |
How we rank similar stocks
Similarity is scored by sector match (baseline), industry match (priority boost), log-scale market cap proximity, and valuation multiple closeness (P/E and dividend yield). Same-industry peers surface first, then nearest-size same-sector peers.